How Meaningful Use (MU) Stage 3 may impact one central cancer registry’s progress in MU Stage 2
Jeannette Jackson-Thompson, MA, MSPH, PhD1, Iris Zachary, PhD, MSHI, CTR2 and Chester Schmaltz, PhD3
(1)University of Missouri (MU) School of Medicine, Columbia, MO, (2)University of Missouri, Columbia, MO, (3)University of Missouri--Columbia, School of Medicine, Columbia, MO